首页> 外文期刊>BMC Musculoskeletal Disorders >Clinical and radiographic outcomes of a trabecular titanium? acetabular component in hip arthroplasty: results at minimum 5?years follow-up
【24h】

Clinical and radiographic outcomes of a trabecular titanium? acetabular component in hip arthroplasty: results at minimum 5?years follow-up

机译:小梁钛的临床和影像学结果?髋关节置换术中的髋臼组件:至少随访5年的结果

获取原文
           

摘要

Aim of this prospective study was to evaluate mid-term clinical and radiographic outcomes in total hip arthroplasty using an acetabular cup made of an innovative biomaterial, Trabecular Titanium?, whose highly porous structure and mechanical properties have been designed to mimic those of the natural bone, thus promoting a more physiological load transfer and a more durable fixation. Between September 2007 and November 2009, 134 total hip replacements and eight revisions were carried out using DELTA-TT primary cups (Lima Corporate, Villanova di San Daniele del Friuli, Italy) in 133 consecutive patients. Mean age was 57.5?±?14.7 SD (18–92) years. Diagnosis was primarily hip osteoarthritis in 85 (63?%) cases, developmental dysplasia of the hip (DDH) in 24 (18?%) and hip avascular necrosis (AVN) in 10 (7?%). All the revision procedures were due to aseptic loosening of the original implant. Approval of the Institutional Review Board of the IRCCS Policlinico San Matteo in Pavia was obtained for this study. Mean follow-up was 72.7?±?7.9 SD (60–86) months. Average Harris Hip Score (HHS) significantly increased from 44.2?±?5.4 SD (35–52) preoperatively to 95.9?±?3.5 SD (88–100) at the last follow-up. No major post-operative complications were observed. 99.3?% of the acetabular components were radiographically stable at the last follow-up, without any radiolucent lines, sclerotic areas or periprosthetic osteolysis. Kaplan-Meier survival rate was 99.3?% at 5?years (95?% confidence interval). This first account on the mid-term clinical performance of the DELTA-TT cup shows primary and secondary stability, thus representing an optimal solution for patients with high demands or affected by severe hip conditions.
机译:这项前瞻性研究的目的是使用由创新的生物材料Trabecular Titanium?制造的髋臼杯评估全髋关节置换术的中期临床和影像学结果,其高度多孔的结构和机械性能旨在模仿天然骨的髋臼杯,从而促进更多的生理负荷转移和更持久的固定。在2007年9月至2009年11月之间,使用DELTA-TT初级杯(意大利利马公司(Lima Corporate),维拉诺瓦迪圣丹尼尔·德尔弗留利)对133位患者进行了134次全髋关节置换和八次翻修。平均年龄为57.5±14.7 SD(18-92)岁。诊断主要为85例(63%)的髋骨关节炎,24例(18%)的髋部发育不良(DDH)和10例(7%)的髋部无血管坏死(AVN)。所有的修订程序都是由于原始植入物的无菌松动造成的。此项研究获得了帕维亚IRCCS Policlinico San Matteo机构审查委员会的批准。平均随访时间为72.7±±7.9 SD(60-86)个月。平均Harris髋关节评分(HHS)从术前的44.2±±5.4 SD(35-52)显着提高到最后一次随访时的95.9±±3.5 SD(88-100)。没有观察到重大的术后并发症。在最后一次随访中,有99.3%的髋臼成分在射线照相方面稳定,没有任何射线可透的线,硬化区域或假体周围的骨溶解。 Kaplan-Meier在5年时的生存率为99.3%(置信区间为95%)。关于DELTA-TT杯中期临床表现的第一个说明显示出主要和次要稳定性,因此代表了对高需求或严重髋部疾病影响的患者的最佳解决方案。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号